Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

OncoCyte Corp (OCX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow OncoCyte's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.590 -0.160    -5.82%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
2.580
-0.010
-0.386%
19:04:46 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 35,975
  • Bid/Ask: 2.580 / 2.660
  • Day's Range: 2.580 - 2.740
OncoCyte 2.590 -0.160 -5.82%

OCX Recent Sentiments

 
This page contains information on users’ sentiments for the OncoCyte Corp stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 16, 2024 Paulo Antunes   3.000 Mar 08, 2024 @ 3.000 0.00%
Oct 26, 2023 ΧΡΗΣΤΟΣ ΜΑΡΓΕΤΗΣ   2.500 Nov 30, 2023 @ 3.800 -52.00%
Sep 18, 2023 Ольга Митина   3.405 Nov 30, 2023 @ 3.800 +11.60%
Sep 12, 2023 Khouloud Rahmeni   3.390 Nov 30, 2023 @ 3.800 +12.09%
Jul 28, 2023 Gil Santos   4.170 Nov 30, 2023 @ 3.800 +8.87%
Jul 06, 2023 abraham woldeselasie   86.000 Nov 30, 2023 @ 3.800 -95.58%
Jul 06, 2023 abraham woldeselasie   86.000 Nov 30, 2023 @ 3.800 -95.58%
Apr 21, 2023 Said Floulou   0.273 Apr 24, 2023 @ 0.277 +1.47%
Apr 10, 2023 Kawa Uzan   0.350 May 09, 2023 @ 0.268 -23.40%
Mar 28, 2023 Fernando Quintero...   0.284 Apr 21, 2023 @ 0.270 -4.93%
Mar 16, 2023 Robbert Kuipers   0.320 Apr 07, 2023 @ 0.310 -3.13%
Mar 16, 2023 Robbert Kuipers   0.310 Mar 16, 2023 @ 0.319 +2.90%
Mar 16, 2023 Robbert Kuipers   0.295 Mar 16, 2023 @ 0.310 +5.08%
Mar 16, 2023 Robbert Kuipers   0.320 Mar 16, 2023 @ 0.295 -7.81%
Mar 16, 2023 Robbert Kuipers   0.320 Mar 16, 2023 @ 0.320 0.00%
Mar 16, 2023 Narciso Junior   0.324 Apr 07, 2023 @ 0.310 -4.32%
Mar 16, 2023 Andreas Schatz   0.317 Apr 07, 2023 @ 0.310 -2.21%
Feb 13, 2023 Robbert Kuipers   0.450 Mar 10, 2023 @ 0.343 -23.69%
Feb 13, 2023 Robbert Kuipers   0.450 Feb 13, 2023 @ 0.450 0.00%
Dec 27, 2022 jose maria Gonzalvez   0.390 Jan 20, 2023 @ 0.451 +15.51%
Nov 17, 2022 Robbert Kuipers   0.424 Dec 09, 2022 @ 0.450 +6.16%
Nov 17, 2022 Robbert Kuipers   0.424 Nov 17, 2022 @ 0.424 0.00%
Nov 16, 2022 Colin Chan   0.386 Dec 09, 2022 @ 0.450 +16.61%
Sep 09, 2022 Robbert Kuipers   0.890 Sep 12, 2022 @ 0.900 +1.12%
Aug 18, 2022 Andreas Schatz   0.924 Sep 09, 2022 @ 0.873 -5.54%
Jul 11, 2022 Juanjo Feliz   0.900 Aug 05, 2022 @ 0.986 -9.56%
May 27, 2022 Jakub Simanek   1.030 Jun 17, 2022 @ 0.965 -6.33%
Jan 19, 2022 Trader Stock   1.705 Feb 11, 2022 @ 1.620 -4.99%
Oct 25, 2021 Kelly Robinson   3.410 Nov 19, 2021 @ 2.750 +19.35%
Oct 20, 2021 Avi Ben Yair   3.340 Nov 12, 2021 @ 3.060 -8.38%
Sep 30, 2021 Hao Wang   3.600 Oct 22, 2021 @ 3.410 -5.28%
Aug 25, 2021 la popeye   4.290 Sep 17, 2021 @ 3.970 -7.46%
Aug 12, 2021 Markus Flemming   4.750 Sep 03, 2021 @ 4.200 -11.58%
Aug 12, 2021 Robbert Kuipers   5.010 Sep 03, 2021 @ 4.200 -16.17%
Aug 12, 2021 Robbert Kuipers   5.000 Aug 12, 2021 @ 5.000 0.00%
Jun 25, 2021 Juanjo Álvarez...   5.600 Jul 16, 2021 @ 5.300 -5.36%
Jun 11, 2021 Kondate Rk   5.430 Jul 02, 2021 @ 5.890 +8.47%
May 11, 2021 Dr Abbas Ghadialy   4.130 Jun 04, 2021 @ 5.060 +22.52%
Apr 21, 2021 Robbert Kuipers   4.780 May 14, 2021 @ 3.900 -18.51%
Apr 14, 2021 Kondate Rk   5.200 May 07, 2021 @ 4.280 -17.69%
Mar 23, 2021 Dr Abbas Ghadialy   5.350 Apr 16, 2021 @ 4.800 -10.28%
Mar 18, 2021 Frank Rojas   4.810 Apr 09, 2021 @ 5.320 +10.50%
Mar 04, 2021 namir almokhtar   4.040 Mar 26, 2021 @ 4.740 +17.33%
Mar 04, 2021 arjan Olomani   4.600 Mar 26, 2021 @ 4.740 +3.04%
Mar 04, 2021 arjan Olomani   4.600 Mar 26, 2021 @ 4.740 +3.04%
Mar 04, 2021 arjan Olomani   4.600 Mar 26, 2021 @ 4.740 +3.04%
Mar 02, 2021 Jeremy Lucas   4.870 Mar 26, 2021 @ 4.740 -2.67%
Feb 16, 2021 Rodrigo Sozo   6.210 Mar 12, 2021 @ 3.720 -40.10%
Feb 05, 2021 Dr Abbas Ghadialy   5.870 Feb 26, 2021 @ 4.960 -15.50%
Feb 05, 2021 שמוליק body   5.860 Feb 26, 2021 @ 4.960 -15.36%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCX Comments

Write your thoughts about OncoCyte Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Marielle Velasco
Marielle Velasco Dec 17, 2020 6:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is thus going
Tariq Matloob
Tariq Matloob Dec 16, 2020 7:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oncocyte Soars on Licensing Deal With Chinese FirmThe cancer detection company said it has licensed a lung cancer test to China’s Burning Rock Biotech.DAN WEIL20 HOURS AGO
Sebastian Melin
Sebastian Melin Dec 15, 2020 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just stopped dead in its tracks? :(
Brijesh Patel
Brijesh Patel Dec 15, 2020 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeah it did
Khalil Borashed
Khalil Borashed Oct 01, 2020 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
estimates have projected may approach $15 billion by 2025. yahoo finace the source
Khalil Borashed
Khalil Borashed Oct 01, 2020 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The agreement will allow Oncocyte to increase its test portfolio in the U.S. to address a broader care continuum.
Kelly Robinson
Kelly Robinson Feb 26, 2020 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one if the most inactive stocks. we would like some positive news.
Ramiro Marrero
Ramiro Marrero Jun 25, 2019 7:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news expected soon? What are the future potential of this company. I am considering buy 1k shares? Thanks
Sean Mabingnay
Sean Mabingnay Jan 29, 2019 2:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to God be the glory
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email